A single high dose of idarubicin combined with high-dose ARA-C for treatment of first relapse in childhood 'high-risk' acute lymphoblastic leukaemia: a study of the AIEOP group.
Testi AM, Del Giudice I, Arcese W, Moleti ML, Giona F, Basso G, Biondi A, Conter V, Messina C, Rondelli R, Micozzi A, Micalizzi C, Barisone E, Locatelli F, Dini G, Aricò M, Casale F, Comis M, Ladogana S, Lippi A, Mura R, Pinta MF, Santoro N, Valsecchi MG, Masera G, Mandelli F; AIEOP Cooperative Group.
Testi AM, et al. Among authors: micalizzi c.
Br J Haematol. 2002 Sep;118(3):741-7. doi: 10.1046/j.1365-2141.2002.03706.x.
Br J Haematol. 2002.
PMID: 12181040
Free article.
Clinical Trial.